Skip to content

Assessment of Amnioninfusion for improving perinatal outcomes after midtrimester preterm prelabour rupture of membranes (PPROMEXIL III)

Assessment of Amnioninfusion for improving perinatal outcomes after midtrimester preterm prelabour rupture of membranes (PPROMEXIL III) - PPROMEXIL III

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39269
Enrollment
56
Registered
2011-11-02
Start date
2012-06-15
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perinatal mortality. The number of stillbirths and deaths in the first week of life

Interventions

Random allocation to (repeated) abdominal amnioninfusion (intervention) or expectant management (control).

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All women with a singleton pregnancy who were first diagnosed between 16 and 24 weeks gestational age with oligohydramnios secondary to PPROM, at least 72 hours after PPROM was diagnosed, but no longer than 21 days after the diagnosis of oligohydramnion, are eligible for the trial.

Exclusion criteria

Exclusion criteria: Women having signs of premature uterine contractions, intra uterine infection, or women having a maternal disease (hypertension, HELLP syndrome, preeclampsia or other) as reason for delivery. Placental or major structural fetal anomalies. Signs of cervical incompetence. Women whose child has signs of fetal distress (abnormal biophysical profile).

Design outcomes

Primary

MeasureTime frame
Primary outcome is perinatal mortality.

Secondary

MeasureTime frame
Secondary outcomes are: Lethal pulmonary hypoplasia, non-lethal pulmonary hypoplasia, survival till discharge from NICU, neonatal mortality, chronic lung disease (CLD), number of days ventilatory support, necrotizing enterocolitis (NEC) more tha stage I, periventricular leucomalacia (PVL) more than grade I, severe intraventricular hemorrhage (IVH) more than grade II, proven neonatal sepsis, gestational age at delivery, time to delivery, indication for delivery, succesfull amnioninfusion, placental abruption, cord prolaps, chorioamnionitis, fetal trauma due to puncture.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)